bf/NASDAQ:ACAD_icon.jpeg

COM:ACADIA

Acadia Pharmaceuticals

  • Stock

Last Close

16.18

22/11 21:00

Market Cap

2.72B

Beta: -

Volume Today

1.40M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
2.09M
-
4.71M
125.70%
4.66M
1.11%
5.21M
11.73%
8.01M
53.90%
8.78M
9.61%
7.26M
17.34%
21.23M
192.45%
average payables
873.50K
-
1.19M
36.69%
1.84M
54.44%
2.79M
51.41%
6.35M
127.40%
5.98M
5.87%
5.19M
13.08%
7.86M
51.27%
7.68M
2.20%
9.81M
27.67%
15.14M
54.36%
average receivables
482K
-
1.30M
169.92%
4.39M
237.36%
12.79M
191.30%
23.11M
80.75%
32.83M
42.07%
44.08M
34.26%
57.81M
31.16%
64.21M
11.07%
82.72M
28.82%
book value per share
2.12
-
3.18
49.77%
1.99
37.62%
4.47
125.40%
2.73
38.88%
3.78
38.39%
4.75
25.49%
3.99
16.09%
3.37
15.43%
2.48
26.52%
2.64
6.42%
capex per share
-0.01
-
-0.00
74.33%
-0.02
1,049.47%
-0.08
285.64%
-0.01
91.93%
-0.02
156.21%
-0.01
54.80%
-0.05
528.73%
-0.01
85.50%
-0.24
-
capex to depreciation
-7.82
-
-0.87
88.83%
-3.31
278.71%
-5.20
57.15%
-0.30
94.24%
-0.71
138.83%
-0.41
42.90%
-2.59
533.96%
-0.34
87.03%
-7.21
-
capex to operating cash flow
0.02
-
0.00
86.07%
0.02
548.79%
0.05
157.01%
0.00
91.75%
0.01
244.12%
0.01
41.76%
0.06
645.86%
0.01
83.98%
-2.40
-
capex to revenue
-0.54
-
-1.50
177.91%
-35.10
2,239.89%
-0.55
98.44%
-0.01
98.81%
-0.01
47.63%
-0.00
65.31%
-0.02
415.81%
-0.00
86.51%
-0.06
-
cash per share
2.17
-
3.32
52.99%
2.14
35.53%
4.57
113.59%
2.78
39.03%
3.74
34.36%
4.74
26.66%
4.02
15.22%
3.24
19.23%
2.58
20.54%
2.68
3.92%
days of inventory on hand
345.86
-
146.67
57.59%
81.04
44.74%
118.10
45.72%
171.97
45.62%
150.28
12.61%
238.26
58.54%
285.89
19.99%
days payables outstanding
324.08
-
245.55
24.23%
63.06
74.32%
134.51
113.28%
150.85
12.15%
131.12
13.08%
457.63
249.02%
140.02
69.40%
days sales outstanding
2.93K
-
9.80K
234.26%
150.37
98.47%
53.86
64.18%
45.32
15.85%
40.77
10.04%
41.55
1.90%
49.26
18.58%
44.51
9.64%
51.43
15.53%
debt to assets
0.01
-
0.06
406.21%
0.09
45.36%
0.11
14.61%
0.08
27.59%
debt to equity
0.01
-
0.08
464.03%
0.12
50.74%
0.15
29.99%
0.13
14.43%
dividend yield
earnings yield
-0.02
-
-0.03
69.06%
-0.05
53.05%
-0.08
77.19%
-0.08
3.48%
-0.12
52.80%
-0.04
68.81%
-0.03
10.39%
-0.04
33.86%
-0.08
87.23%
-0.01
85.76%
enterprise value
2.13B
-
3.03B
42.03%
3.49B
15.19%
3.18B
8.83%
3.62B
13.98%
1.91B
47.21%
6.11B
219.75%
8.13B
32.97%
3.65B
55.04%
2.52B
31.01%
5.00B
98.23%
enterprise value over ebitda
-55.74
-
-32.45
41.78%
-21.17
34.76%
-11.65
44.99%
-12.39
6.34%
-7.73
37.62%
-24.80
220.91%
-28.37
14.39%
-21.44
24.41%
-11.28
47.41%
-73.68
553.48%
ev to operating cash flow
-67.06
-
-45.55
32.08%
-28.62
37.17%
-15.10
47.22%
-16.63
10.09%
-11.42
31.33%
-40.45
254.32%
-59.70
47.58%
-29.08
51.29%
-22.11
23.98%
299.23
1,453.45%
ev to sales
1.86K
-
25.21K
1,255.24%
57.14K
126.60%
183.35
99.68%
29.00
84.18%
8.54
70.54%
18.03
111.05%
18.40
2.06%
7.55
58.98%
4.87
35.43%
6.88
41.14%
free cash flow per share
-0.38
-
-0.68
81.29%
-1.23
79.80%
-1.90
54.12%
-1.78
6.03%
-1.34
24.87%
-1.03
22.81%
-0.91
11.67%
-0.79
13.54%
-0.71
10.72%
-0.14
79.79%
free cash flow yield
-0.02
-
-0.02
42.69%
-0.03
60.13%
-0.07
90.51%
-0.06
10.00%
-0.08
39.89%
-0.02
70.82%
-0.02
29.31%
-0.03
98.03%
-0.04
30.90%
-0.00
89.73%
graham net net
2.09
-
3.16
51.45%
1.93
38.91%
4.26
120.79%
2.52
40.94%
3.44
36.62%
4.38
27.42%
3.30
24.73%
2.58
21.71%
1.73
32.92%
1.32
23.76%
graham number
4.60
-
8.25
79.36%
8.54
3.53%
15.36
79.75%
12.05
21.52%
12.84
6.56%
13.07
1.76%
12.67
3.07%
8.91
29.70%
8.63
3.13%
4.71
45.41%
income quality
0.84
-
0.72
14.19%
0.74
3.10%
0.78
4.68%
0.75
2.90%
0.68
9.27%
0.64
5.95%
0.48
24.72%
0.75
54.80%
0.53
29.46%
-0.27
151.61%
intangibles to total assets
0
-
0
0
0.01
Infinity%
0.01
15.21%
0.01
47.79%
0.00
56.11%
0.00
57.11%
0
100%
0
0.09
Infinity%
interest coverage
-33.83
-
interest debt per share
0.07
-
0.31
373.26%
0.40
27.48%
0.42
5.70%
0.35
17.71%
inventory turnover
1.06
-
2.49
135.81%
4.50
80.98%
3.09
31.37%
2.12
31.33%
2.43
14.43%
1.53
36.92%
1.28
16.66%
invested capital
0.01
-
0.08
464.03%
0.12
50.74%
0.15
29.99%
0.13
14.43%
market cap
2.14B
-
3.09B
44.15%
3.59B
16.19%
3.34B
6.86%
3.69B
10.48%
2.05B
44.55%
6.30B
207.65%
8.41B
33.57%
3.75B
55.46%
2.57B
31.29%
5.13B
99.27%
net current asset value
181.37M
-
308.65M
70.17%
196.85M
36.22%
505.15M
156.61%
324.26M
35.81%
464.98M
43.40%
676.20M
45.43%
562.01M
16.89%
458.60M
18.40%
320.54M
30.10%
298.92M
6.74%
net debt to ebitda
0.31
-
0.66
116.59%
0.62
6.48%
0.60
3.34%
0.24
60.42%
0.54
129.40%
0.74
36.53%
0.98
32.13%
0.54
45.47%
0.24
55.88%
1.94
720.00%
net income per share
-0.44
-
-0.95
114.79%
-1.63
71.85%
-2.34
43.35%
-2.36
0.77%
-1.94
17.94%
-1.60
17.49%
-1.79
11.98%
-1.05
41.56%
-1.34
27.71%
-0.37
71.99%
operating cash flow per share
-0.37
-
-0.68
84.32%
-1.21
77.17%
-1.82
50.05%
-1.78
2.15%
-1.32
25.55%
-1.03
22.40%
-0.87
15.70%
-0.78
9.53%
-0.71
9.92%
0.10
114.46%
payables turnover
1.13
-
1.49
31.98%
5.79
289.37%
2.71
53.11%
2.42
10.83%
2.78
15.05%
0.80
71.35%
2.61
226.84%
receivables turnover
0.12
-
0.04
70.08%
2.43
6,417.93%
6.78
179.20%
8.05
18.84%
8.95
11.16%
8.79
1.87%
7.41
15.67%
8.20
10.67%
7.10
13.44%
research and ddevelopement to revenue
23.34
-
505.02
2,063.93%
1.21K
139.79%
5.73
99.53%
1.19
79.15%
0.84
29.99%
0.71
15.23%
0.72
1.90%
0.49
31.55%
0.70
41.36%
0.48
30.76%
return on tangible assets
-0.20
-
-0.28
41.60%
-0.74
160.82%
-0.49
33.91%
-0.76
55.93%
-0.46
40.11%
-0.30
34.10%
-0.36
19.55%
-0.24
33.45%
-0.37
53.24%
-0.09
75.59%
revenue per share
0.01
-
0.00
90.76%
0.00
50.88%
0.15
24,577.16%
1.02
581.05%
1.77
73.55%
2.30
30.28%
2.81
21.89%
3.02
7.44%
3.20
6.05%
4.43
38.61%
roe
-0.21
-
-0.30
43.41%
-0.82
175.50%
-0.52
36.41%
-0.86
64.88%
-0.51
40.71%
-0.34
34.25%
-0.45
33.46%
-0.31
30.89%
-0.54
73.79%
-0.14
73.68%
roic
-0.21
-
-0.30
42.94%
-0.83
174.71%
-0.53
35.95%
-0.88
65.54%
-0.52
40.70%
-0.35
33.36%
-0.40
15.14%
-0.26
35.18%
-0.44
70.10%
-0.16
62.62%
sales general and administrative to revenue
11.11
-
272.90
2,356.53%
1.49K
445.47%
10.76
99.28%
2.04
81.02%
1.19
41.85%
0.96
19.12%
0.88
8.39%
0.82
7.03%
shareholders equity per share
2.12
-
3.18
49.77%
1.99
37.62%
4.47
125.40%
2.73
38.88%
3.78
38.39%
4.75
25.49%
3.99
16.09%
3.37
15.43%
2.48
26.52%
2.64
6.42%
stock based compensation to revenue
4.99
-
133.66
2,579.72%
658.92
392.99%
3.19
99.52%
0.60
81.04%
0.36
39.74%
0.24
33.43%
0.19
21.23%
0.13
31.24%
0.13
0.35%
0.09
30.66%
tangible asset value
182.13M
-
309.49M
69.93%
199.76M
35.45%
511.40M
156.00%
329.75M
35.52%
475.02M
44.05%
696.55M
46.64%
625.90M
10.14%
540.89M
13.58%
400.41M
25.97%
366.26M
8.53%
tangible book value per share
2.12
-
3.18
49.77%
1.99
37.62%
4.41
122.35%
2.69
39.07%
3.75
39.52%
4.73
26.10%
3.98
15.93%
3.37
15.28%
2.48
26.52%
2.64
6.42%
working capital
181.38M
-
308.78M
70.24%
197.09M
36.17%
505.31M
156.39%
324.45M
35.79%
466.54M
43.80%
685.42M
46.92%
611.65M
10.76%
521.75M
14.70%
382.31M
26.73%
361.87M
5.35%

All numbers in (except ratios and percentages)